Galmed Pharmaceuticals
GLMD
GLMD
21 hedge funds and large institutions have $878K invested in Galmed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
21
Holders Change
-1
Holders Change %
-4.55%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$17.4K |
2 |
VF
2
Virtu Financial
New York
|
$13K |
3 |
3
Morgan Stanley
New York
|
$87.1K |
4 |
4
BNP Paribas Financial Markets
Paris,
France
|
$5.85K |
5 |
AF
5
Allworth Financial
Folsom,
California
|
$107 |
Top Sellers
1 |
BI
1
BVF Inc
San Francisco,
California
|
$575K |
2 |
2
Millennium Management
New York
|
$56K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$1.84K |
4 |
4
Jane Street
New York
|
$5.63K |
5 |
SG
5
StoneX Group
New York
|
$0 |